by The genetic analysis market size is poised to grow by USD 23.60 billion by 2033 from USD 10.55 billion in 2023, exhibiting a CAGR of 8.39% during the forecast period 2024-2033.
Key Points
- North America dominated the market in 2023.
- By product, the reagents & kits segment dominated the market in 2023.
- By test, the disease diagnostic testing segment dominated the largest share in 2023.
- By technology, the real-time PCR system segment dominated the genetic analysis market in 2023.
- By application, the infectious diseases segment dominated the market in 2023.
- By end-use, the research & development laboratories segment dominated the market in 2023.
Precedence Research has conducted a comprehensive market study that provides valuable insights into the performance of the market during the forecast period. The study identifies significant trends that are shaping the growth of the Genetic analysis market. In this recently published report, essential dynamics such as drivers, restraints, and opportunities are highlighted for both established market players and emerging participants involved in production and supply.
To begin with, the Genetic analysis Market report features an executive summary that offers a concise overview of the marketplace. It outlines the key players and industry categories expected to have an impact on the market in the coming years. The executive summary provides an unbiased summary of the market.
Get a Sample Report: https://www.precedenceresearch.com/sample/3922
Genetic Analysis Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 8.39% |
| Global Market Size in 2023 | USD 10.55 Billion |
| Global Market Size by 2033 | USD 23.60 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Test, By Technology, By Application, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Farming As a Service Market Size to Attain USD 16.75 Bn By 2033
The empirical study on the global Genetic analysis market primarily focuses on the drivers in subsequent sections. It demonstrates how changing demographics are projected to influence the supply and demand dynamics in the Genetic analysis Market. Our market report for the Genetic analysis market also delves into the significant rules and regulations that are likely to impact the future growth of this sector. Moreover, in order to comprehend the underlying demand factors, industry experts have provided insights into its fundamental origins.
Genetic Analysis Market Companies
- Thermo Fisher Scientific
- Abbott Laboratories
- PerkinElmer, Inc.
- BioRad Laboratories
- AutoGenomics Inc.
- ELITech Group
- IntegraGen
- Quest Diagnostics Inc.
- Hoffmann-La Roche AG
- Celera Group
- Qiagen
- Danaher (Cepheid)
Data Sources and Methodology
To gather comprehensive insights on the Global Genetic analysis Market, we relied on a range of data sources and followed a well-defined methodology. Our approach involved interactions with industry experts and key stakeholders across the market’s value chain, including management organizations, processing organizations, and analytics service providers.
We followed a rigorous data analysis process to ensure the quality and credibility of our research. The gathered information was carefully evaluated, and relevant quantitative data was subjected to statistical analysis. By employing robust analytical techniques, we were able to derive meaningful insights and present a comprehensive overview of the Global Genetic analysis Market.
The most resonating, simple, genuine, and important causes because of which you must decide to buy the Genetic analysis market report exclusively from precedence research
- The research report has been meticulously crafted to provide comprehensive knowledge on essential marketing strategies and a holistic understanding of crucial marketing plans spanning the forecasted period from 2024 to 2033.
Key Features of the Report:
- Comprehensive Coverage: The report extensively encompasses a detailed explanation of highly effective analytical marketing methods applicable to companies across all industry sectors.
- Decision-Making Enhancement: It outlines a concise overview of the decision-making process while highlighting key techniques to enhance it, ensuring favorable business outcomes in the future.
- Articulated R&D Approach: The report presents a well-defined approach to conducting research and development (R&D) activities, enabling accurate data acquisition on current and future marketing conditions.
Market Segmentation:
By Product
- Reagents & Kits
- Instruments
- Software
By Test
- Predictive Genetic Testing
- Carrier Testing
- Prenatal and Newborn Testing
- Disease Diagnostic Testing
- Pharmacogenomic Testing
- Others
By Technology
- Next-Generation Sequencing (NGS)
- Real-Time PCR System
- Others
By Application
- Cancer
- Genetic Diseases
- Cardiovascular Diseases
- Rare Diseases
- Infectious Diseases
- Others
By End-use
- Hospitals
- Research & Development Laboratories
- Diagnostic Centers
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Reasons to Consider Purchasing the Report:
- Enhance your market research capabilities by accessing this comprehensive and precise report on the global Genetic analysis market.
- Gain a thorough understanding of the overall market landscape and be prepared to overcome challenges while ensuring robust growth.
- Benefit from in-depth research and analysis of the latest trends shaping the global Genetic analysis market.
- Obtain detailed insights into evolving market trends, current and future technologies, and strategic approaches employed by key players in the global Genetic analysis market.
- Receive valuable recommendations and guidance for both new entrants and established players seeking further market expansion.
- Discover not only the cutting-edge technological advancements in the global Genetic analysis market but also the strategic plans of industry leaders.
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Genetic Analysis Market
5.1. COVID-19 Landscape: Genetic Analysis Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Genetic Analysis Market, By Product
8.1. Genetic Analysis Market, by Product, 2024-2033
8.1.1. Reagents & Kits
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Software
8.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Genetic Analysis Market, By Test
9.1. Genetic Analysis Market, by Test, 2024-2033
9.1.1. Predictive Genetic Testing
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Carrier Testing
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Prenatal and Newborn Testing
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Disease Diagnostic Testing
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Pharmacogenomic Testing
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Genetic Analysis Market, By Technology
10.1. Genetic Analysis Market, by Technology, 2024-2033
10.1.1. Next-Generation Sequencing (NGS)
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Real-Time PCR System
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Genetic Analysis Market, By Application
11.1. Genetic Analysis Market, by Application, 2024-2033
11.1.1. Cancer
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Genetic Diseases
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Cardiovascular Diseases
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Rare Diseases
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Infectious Diseases
11.1.5.1. Market Revenue and Forecast (2021-2033)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Genetic Analysis Market, By End-use
12.1. Genetic Analysis Market, by End-use, 2024-2033
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Research & Development Laboratories
12.1.2.1. Market Revenue and Forecast (2021-2033)
12.1.3. Diagnostic Centers
12.1.3.1. Market Revenue and Forecast (2021-2033)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 13. Global Genetic Analysis Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.5. Market Revenue and Forecast, by End-use (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.6.5. Market Revenue and Forecast, by End-use (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.7.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.7.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.7.5. Market Revenue and Forecast, by End-use (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.5. Market Revenue and Forecast, by End-use (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.7. Market Revenue and Forecast, by Application (2021-2033)
13.2.8. Market Revenue and Forecast, by End-use (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.9.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.10. Market Revenue and Forecast, by Application (2021-2033)
13.2.11. Market Revenue and Forecast, by End-use (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.12.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.12.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.13. Market Revenue and Forecast, by End-use (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.14.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.14.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.15. Market Revenue and Forecast, by End-use (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.5. Market Revenue and Forecast, by End-use (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.7. Market Revenue and Forecast, by End-use (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.9. Market Revenue and Forecast, by End-use (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.10.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.10.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.10.5. Market Revenue and Forecast, by End-use (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.11.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.11.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.11.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.7. Market Revenue and Forecast, by End-use (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.9. Market Revenue and Forecast, by End-use (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.10.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.10.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.10.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.11.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.11.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.11.5. Market Revenue and Forecast, by End-use (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.5. Market Revenue and Forecast, by End-use (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.7. Market Revenue and Forecast, by End-use (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.8.5. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 14. Company Profiles
14.1. Thermo Fisher Scientific
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott Laboratories
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. PerkinElmer, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. BioRad Laboratories
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. AutoGenomics Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. ELITech Group
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. IntegraGen
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Quest Diagnostics Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Hoffmann-La Roche AG
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Celera Group
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Unlocking Market Insights through Data Excellence
The “Precedence Statistics” flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today’s dynamic and data-driven world.
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
Precedence Statistics – Empowering Your Data Insights
Contact Us
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
